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A Novel Locus for Autosomal Recessive Peripheral Neuropathy
in the EGR2 Region on 10q23
Tamara Rogers,1 David Chandler,1 Dora Angelicheva,1 P. K. Thomas,3 Bryan Youl,3
Ivailo Tournev,4 Velina Gergelcheva,4, and Luba Kalaydjieva1,2
1Centre for Human Genetics, Edith Cowan University, and 2Western Australian Institute for Medical Research, Perth; 3Institute of Neurology,
University College, London; and 4Department of Neurology, Medical University, Sofia, Bulgaria
During our studies of Romany (Gypsy) families with hereditary motor and sensory neuropathy–Lom, we have
identified a large kindred with two independently segregating autosomal recessive neuropathies. The novel disorder,
named “hereditary motor and sensory neuropathy–Russe” (HMSNR), presented as a severe disabling form of
Charcot-Marie-Tooth disease with prominent sensory loss, moderately reduced motor nerve conduction velocity,
and a high threshold for electrical nerve stimulation. A genome scan in two branches of the large kindred detected
linkage to the 10q22-q23 region containing the early growth response 2 gene (EGR2), a transcription factor with
a key role in peripheral nerve myelination. The results of sequence analysis and the detection of an intragenic
polymorphism allowed us to exclude EGR2 as the HMSNR gene. Further analysis done using linkage and recom-
bination mapping refined the position of the HMSNR gene to a small interval on 10q23.2, flanked by markers
D10S581 and D10S1742, telomeric to EGR2. In this interval, a conserved seven-marker haplotype is shared by
all disease chromosomes, suggesting a single founder mutation. The homozygosity region is contained in bacterial-
artificial-chromosome contig 1570 of the Sanger Centre physical map and has an estimated physical size of ∼500
kb.
Introduction
Hereditary motor and sensory neuropathies (HMSNs)
are a heterogeneous group of disorders including a grow-
ing number of clinically and genetically distinct auto-
somal recessive (AR) conditions (Ben Othmane et al.
1993; Bolino et al. 1996; Casaubon et al. 1996; LeGuern
et al. 1996; Bouhouche et al. 1999; Othmane et al. 1999;
Delague et al. 2000; Thomas, in press). Although the
common autosomal dominant demyelinating neuropa-
thies are now known to result from mutations in struc-
tural myelin components (Lupski 1998; Keller and
Chance 1999; Schenone and Mancardi 1999), AR forms
are more likely to reveal defects in the mechanisms of
cell growth, differentiation, and signaling, as illustrated
by the recent identification of the first two genes of this
group (Bolino et al. 2000; Kalaydjieva et al. 2000). Un-
derstanding the molecular basis of these conditions can
therefore be expected to contribute significantly to the
current limited understanding of the biology and path-
ophysiology of the peripheral nervous system.
Two of the known AR forms of HMSNs—namely,
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HMSN-Lom (HMSNL [MIM 601455]) (Kalaydjieva
et al. 1996, 1998) and the congenital cataracts/facial
dysmorphism neuropathy syndrome (CCFDN [MIM
604168]) (Angelicheva et al. 1999; Tournev et al. 1999)
—have been identified and characterized in studies of
the Romany (Gypsies). In the course of our previous
investigations of HMSNL, we detected a large kindred
with multiple affected members (fig. 1). In some
branches of this kindred, linkage to theHMSNL region
on 8q24 and a phenotype that matched the clinical cri-
teria for HMSNL were shown. In other branches of the
kindred, linkage to 8q24 was excluded, suggesting the
segregation of two genetically distinct AR neuropathies.
Clinically, the novel disorder presented as a severe
form of Charcot-Marie-Tooth (CMT) disease. Age at
onset of distal lower-limb weakness was 8–16 years.
Age at onset of upper-limb involvement was variable,
with a range of 10–43 years. The disorder was steadily
progressive, leading to severe disability and total pa-
ralysis of muscles below the knees and, in many cases,
below the elbows, by the 4th or 5th decades of life.
Sensory loss affecting all modalities was a prominent
feature. Motor nerve conduction was unobtainable in
the legs. In the upper limbs, a peculiar combination of
moderately reduced motor nerve conduction velocity
( m/s for the ulnar nerve and31.9 7.05 32.0 6.8
m/s for the median nerve) and a greatly increased thresh-
old for electrical nerve stimulation was observed. Sen-
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Figure 1 Extended pedigree in which HMSNR was identified. Blackened symbols denote subjects affected by HMSNR; symbols containing
a vertical line denote subjects affected by HMSNL, which is the other neuropathy in this kindred.
sory action potentials were absent. Sural nerve–biopsy
specimens demonstrated a depletion of large myelinated
nerve fibers, profuse regenerative activity, and uniformly
reduced thickness of the myelin sheath relative to axonal
diameter, indicating hypomyelination. The disorder was
therefore clinically distinct from the known forms of
AR CMT disease. It was named “hereditary motor and
sensory neuropathy–Russe” (HMSNR), for the city on
the Danube river in northern Bulgaria where most of
the affected individuals reside. A detailed description of
the disease phenotype will be published elsewhere (P.
K. Thomas, I. Tournev, D. Angelicheva, B. Youl, R. H.
M. King, M. Nourallah, J. R. Muddle, and L. Kalay-
djieva, unpublished data). Here we report the genetic
mapping of HMSNR to chromosome 10q23 and the
exclusion of the early growth response 2 gene (EGR2)
as the candidate gene.
Subjects and Methods
Subjects and Pedigrees
Linkage analysis was conducted in two branches of
the extended kindred (figs. 1 and 2a and b). A total of
15 individuals, 11 of whom were affected, were ana-
lyzed. After identification of the candidate region, re-
fined genetic mapping and haplotype analysis included
four additional affected subjects (including two siblings)
from the extended kindred (figs. 1 and 2c). Detailed
clinical and electrophysiological examinations were per-
formed, in all instances, by the same clinical team.
Informed consent was obtained from all individuals
participating in the study. The study complies with the
ethical guidelines of the institutions involved. DNA was
isolated from peripheral blood lymphocytes as described
elsewhere (Miller et al. 1988).
Genotyping Analysis
The ABI Prism Linkage Mapping Sets LMS and LMS
version 2 (PE Biosystems), which have an average inter-
marker distance of 10 cM, were used in the genome scan.
Additional markers for the analysis of chromosome 5q
included D5S2084, D5S2055, D5S2011, D5S2090,
D5S2049, D5S2040, and D5S2057 from the ABI Prism
LMS-HD5 Mapping Set.
For the refined mapping of the candidate area on
chromosome 10q22-q23, the following additional
markers were selected from the Ge´ne´thon database:
D10S1780, D10S578, D10S220, D10S1790,
D10S546, D10S589, D10S1640, D10S1719,
D10S561, D10S581, D10S1670, D10S1646,
D10S210, D10S1647, D10S1672, D10S1742,
D10S1678, D10S560, D10S1665, D10S1685,
D10S1688, D10S606, D10S535, D10S580, and
D10S1730. Marker D10S2480 was chosen from the
Southampton map (Genetic Location Database).
PCR amplification was performed in a 5-ml total vol-
ume containing 10 ng DNA, 500 mM each dNTP, 4–5
mM or 50 ng each primer, 1# Qiagen PCR buffer (Qia-
gen), 1.5 mM MgCl2, and 0.25 U Taq polymerase (Qia-
gen). PCR amplification was done in a 9600 thermal
cycler (PE Biosystems), with use of the following cycling
conditions: denaturation at 94C for 5 min; 15 cycles at
94C for 20 s, 63C–55C (0.5C decrease in annealing
temperature/cycle) for 60 s, and 72C for 30 s; 15 cycles
at 94C for 20 s, 55C for 60 s, and 72C for 60 s; and
final extension at 72C for 5 min.
The PCR products were separated on an ABI Prism
377 DNA Analyzer (PE Biosystems), with use of dena-
turing 5.0% polyacrylamide gels (Long Ranger [FMC
BioProducts]). The genotyping data were processed us-
ing GENESCAN version 3.1, GENOTYPER version 2.5,
and GENBASE version 2.01 (PE Biosystems). Haplo-
types were constructed manually, with markers ordered
according to the physical map of chromosome 10, as
provided by the Sanger Centre.
Statistical Analysis
Linkage analysis was performed under the assump-
tions of AR inheritance, full penetrance, and equal fre-
quencies of marker alleles. For the calculations, consan-
guinity loops were broken, and the pedigree shown in
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Table 1
PCR Primers Used in Sequencing Analysis of the 5′
and 3′ UTRs of EGR2
UTR
PRIMER
Forward Reverse
5′-1 cagaggaaggagggtgtctc ccctactcactttcttggcagc
5′-2 cttccgtgaatgcatgtagc gccgtcacatggctgatttg
5′-3 caaatcagccatgtgacggc gttggactgagcctgggatg
3′-1 cacaacaacactaccacc gatatgctctgattcacc
3′-2 cagtgagtgaagtatagcc gcatgcatcctagtttcagag
3′-3 gcatttatgatctcagagg cactatagtcacaaaccatcc
figure 2b was split into two. The analyses were done
using two different disease-gene frequencies: .001 and
.01. Two-point LOD scores were calculated using the
MLINK program version 5.10 of the LINKAGE package
(Ott 1991). Multipoint parametric linkage analysis was
performed using GENEHUNTER version 1.0 (Kruglyak
et al. 1996). For the genome-scan multipoint calcula-
tions, the maps provided in the ABI Prism LinkageMap-
ping Sets LMS and LMS version 2 (PE Biosystems) were
used. Multipoint analysis of the candidate region on
chromosome 10q relied on the Ge´ne´thon map, from
which the additional markers were selected, despite some
discrepancies with the Sanger Centre physical map.
Sequence Analysis of the EGR2 Gene
The coding regions of EGR2 were amplified from ge-
nomic DNA, with the use of overlapping primers as
described elsewhere (Timmerman et al. 1999; Lupski
Lab Homepage). The 5′ and 3′ UTRswere analyzed using
newly designed primers (table 1). PCR reactions were
performed in a 50-ml volume containing 50 ng DNA,
50 ng each primer, 500 mM each dNTP, 1.5 mMMgCl2,
1 # Qiagen PCR buffer (Qiagen), and 0.125 U Taq
DNA polymerase (Qiagen). A PE 9600 thermal cycler
(PE Biosystems) was used with the following cycling con-
ditions: initial denaturation at 94C for 5 min; 35 cycles
at 94C for 30 s, 66C for 1 min, and 72C for 1 min;
and final extension at 72C for 7 min. PCR products
were purified through QIAquick Spin Columns (Qiagen)
and were sequenced using the PCR primers and Big Dye
Terminator Cycle Sequencing Ready Reaction Kits (PE
Biosystems). The sequencing reactions were run on an
Applied Biosystems model 377 DNA Analyzer (PE Bio-
systems). The initial analysis included two patients and
two unaffected control subjects from Romany families
with other genetic disorders. Data were compared for
patients and control subjects and were also compared
with published EGR2 sequences by use of Sequence
Navigator version 1.0.1 (PE Biosystems). Segregation
analysis of the newly detected single-nucleotide poly-
morphism (SNP) in EGR2was performed through direct
sequencing of exon 2.5c (Timmerman et al. 1999).
Results
Linkage Analysis
As a first step, we examined, in families with
HMSNR, linkage to chromosomal regions containing
known AR HMSN loci, in addition to HMSNL on
8q24, which had already been excluded. Results that
were suggestive of linkage were obtained for the de-
myelinating CMT (CMT4C [MIM 601596]) region on
5q23-q33 (LeGuern et al. 1996), where a two-point
LOD score of 2.27 was calculated for marker D5S471
(recombination fraction [v] 0) and a multipoint LOD
score of 2.75 was obtained. Further analysis with a
higher-density map (additional markers are those
listed in the Subjects and Methods section) reduced
the multipoint LOD score to 0.34 (not shown).
A genomewide analysis was then conducted using
a 10-cM map density. Evidence of linkage was ob-
tained over a 140-cM region on chromosome 10q,
flanked by markers D10S208 and D10S1686 (table
2). The multipoint LOD score peaked (maximum
value 4.5) in the interval D10S196–D10S537. The
highest two-point LOD score (3.96) was observed at
D10S1652, at v p 0).
Analysis of the EGR2 Gene
The region of linkage contained an obvious can-
didate, the EGR2/Krox20 gene (Joseph et al. 1988),
encoding a transcription factor with a key role in
Schwann-cell differentiation and myelination (Topilko
et al. 1994). Sequencing analysis of the entire coding
sequence and of the 5′ and 3′ UTRs of EGR2 revealed
identical wild-type sequence in individuals with
HMSNR and in control subjects. Nucleotide positions
971 and 1476 conformed with the EGR2 sequence
published under GenBank accession number
AF139463 (Warner et al. 1999). An SNP at position
433 (numbering is based on GenBank accession num-
ber AF139463)—namely, an AT transversion (Warner
et al. 1999)—was nonpolymorphic in our study.
A novel SNP, an AC transversion, was identified at
position 1219 (numbering is based on GenBank acces-
sion number AF139463), resulting in a silent mutation
in codon 362 (R362R). The segregation of this SNP in
the two families with HMSNR was studied by PCR am-
plification and sequencing of exon 2.5c (Timmerman et
al. 1999) of EGR2. The results of this analysis showed
variation, in the polymorphic alleles inherited by the
affected members, both between the two families (fig.
2a and b) and between the branches of the family shown
in figure 2b.
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Table 2
Two-Point LOD Scores Obtained in the Refined Mapping of the 10q22-23 Region
MARKERa
SIZEb
(cM)
TWO-POINT LOD SCORE AT v p
.00 .05 .10 .15 .20 .25 .30 .35 .40
D10S208 60.3 8.83 2.22 1.07 .53 .24 .08 .01 .01 .01
D10S1780 66.9 5.47 .39 .15 .32 .35 .31 .24 .15 .08
D10S578 66.9 5.77 .57 .01 .19 .25 .24 .19 .13 .07
D10S196 72.5 1.35 .22 .35 .35 .30 .23 .16 .10 .05
D10S220 74.2 .99 .57 .67 .62 .52 .40 .28 .17 .08
D10S1790 77.0 3.06 .37 .66 .69 .61 .49 .35 .21 .10
D10S546 81.7 1.60 1.67 1.75 1.60 1.35 1.06 .76 .48 .23
D10S589 83.3 2.08 1.00 1.19 1.14 .99 .79 .58 .37 .19
D10S1652 83.3 3.96 3.48 2.99 2.51 2.03 1.56 1.10 .69 .34
D10S1640 83.3 3.04 2.70 2.35 1.99 1.63 1.26 .90 .57 .28
D10S1719 83.3 .05 1.28 1.20 1.02 .81 .60 .40 .24 .11
D10S561 84.9 2.29 3.39 3.08 2.65 2.17 1.68 1.20 .75 .37
D10S581 88.6 2.04 3.18 2.90 2.51 2.06 1.60 1.14 .71 .35
D10S1670 88.6 1.29 1.90 1.98 1.81 1.55 1.24 .92 .60 .30
D10S1646 89.4 2.93 2.49 2.07 1.66 1.28 .93 .62 .36 .17
D10S2480 91.4 4.09 3.53 2.98 2.45 1.93 1.44 1.00 .60 .29
D10S210 91.4 3.58 3.13 2.66 2.19 1.73 1.29 .89 .54 .26
D10S1647 91.5 5.53 4.87 4.21 3.54 2.87 2.21 1.58 1.00 .50
D10S1672 91.6 4.31 3.75 3.20 2.65 2.13 1.62 1.14 .71 .35
D10S1742 92.1 4.21 3.68 3.15 2.63 2.12 1.63 1.16 .73 .36
D10S1678 92.2 2.25 1.93 1.63 1.33 1.06 .80 .56 .35 .17
D10S560 92.2 2.79 2.40 2.01 1.64 1.29 .96 .66 .40 .19
D10S1665 93.8 3.58 3.16 2.72 2.29 1.85 1.42 1.01 .63 .31
D10S537 93.8 .10 1.56 1.49 1.28 1.02 .76 .51 .30 .14
D10S1685 94.0 1.23 2.73 2.53 2.20 1.82 1.43 1.03 .65 .32
D10S1688 95.6 4.57 4.00 3.42 2.85 2.29 1.75 1.23 .76 .37
D10S606 96.9 1.53 1.53 1.62 1.47 1.22 .95 .67 .41 .19
D10S535 98.1 1.11 2.29 2.07 1.74 1.38 1.03 .70 .42 .20
D10S580 100.5 3.76 .18 .17 .27 .27 .23 .17 .10 .05
D10S1730 103.8 7.24 .91 .09 .24 .36 .37 .31 .21 .11
D10S1686 109.2  1.71 .72 .27 .05 .05 .07 .06 .04
a Italicized markers are from the ABI panel, within and flanking the initial region of linkage (see table
2). D10S1647 (underlined) had the highest two-point LOD score.
b According to Ge´ne´thon.
Refined Mapping of the HMSNR Region
To refine the position of theHMSNR gene, the 10q22-
q23 region was further studied using higher map density
with an average intermarker distance of ∼1.5 cM. The
highest two-point LOD score (5.53) was calculated at
marker D10S1647 (v p 0), which is located 8.2 cM
telomeric of D10S1652, where the initial highest-LOD-
score value was observed (table 2). The multipoint LOD
scores peaked in the interval D10S1647–D10S560, with
a maximum value of 6.43. LOD scores did not change
significantly with the use of different gene frequencies.
Haplotype analysis in the affected families produced
evidence of four recent recombination events, one of
which was proximal (in individual R-11; fig. 2b) and
three of which were distal (in individuals R-42, R-12,
and R-17; fig. 2a, b, and c, respectively). The recom-
bination event in individual R-11 (fig. 2b), occurring
between markers D10S581 and either D10S1646 (un-
informative) or D10S1670, placed the proximal bound-
ary of the HMSNR region at D10S581. Of the three
recombinations seen in the telomeric part of the region,
that which was seen in individual R-17 (fig. 2c) defined
marker D10S537 as the probable distal boundary of the
HMSNR region. The parents in that family were not
available for analysis; therefore, the haplotypes were in-
ferred under assumption of the presence of the most
common haplotype on one of the disease chromosomes.
The D10S581–D10S537 interval spans 5.2 cM.
For this interval, the current sample of 15 affected in-
dividuals from a single large kindred presented with a
total of 10 different haplotypes, of which 8 were the
product of historical recombinations (fig. 3). Three of
the historical recombinations observed in the proximal
part of the region (in haplotypes AB, H, and IJK)
had breakpoints that mapped to the same interval as did
the recent recombination event in individual R-11—
namely, that between markers D10S581 and D10S1646.
In one of the distal historical recombinations (in hap-
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Figure 3 Marker haplotypes in the 5.2-cM interval (D10S581–D10S537) defined by linkage analysis. Markers D10S561 and EGR2 are
included to show the position of EGR2. Marker order is according to the Sanger Centre physical map. Haplotype and EGR2 allele designations
are the same as those used in figure 2. Haplotypes N and M are products of the recent recombinations in individuals R-11 and R-17. The two
affected members of the large kindred, who were not included in the linkage study, displayed haplotypes D/K and H/J. The unblackened area
indicates the assumed ancestral haplotype. Historical recombinations place the HMSNR gene between markers D10S581 and D10S1742.
lotypes A and DE), the breakpoint mapped to the in-
terval D10S1672–D10S1742. Historical recombinations
thus place the HMSNR gene in the region defined by
markers D10S581 and D10S1742. In this interval, all
disease chromosomes from our present sample share a
conserved seven-marker haplotype (fig. 3). The region
spans a genetic distance of 3.5 cM.
The HMSNR Region According to the Sanger Centre
Physical Map
The markers within the conserved region of homozy-
gosity have beenmapped, by the Sanger Centre, to a single
bacterial-artificial-chromosome contig (contig 1570) at
10q23.2. According to the physical map of the region,
EGR2 is located ∼300 kb centromeric to the proximal
boundary of the HMSNR region—that is, centromeric to
marker D10S581. TheHMSNR homozygosity region has
a physical length estimated to be ∼500 kb.
Discussion
The HMSNR phenotype is that of a severe progressive
sensorimotor neuropathy with prominent sensory loss,
intermediate reduction in nerve conduction velocity, and
an increased threshold for electrical stimulation. Both
the clinical features and the genetic data indicate that
this is a novel disorder that is clinically and genetically
distinct from the known forms of AR HMSN (Ohnishi
et al. 1989; Gabree¨ls-Festen et al. 1990, 1991; Ben Oth-
mane et al. 1993; Bolino et al. 1996; LeGuern et al.
1996; Gambardella et al. 1997; Kessali et al. 1997; Bou-
houche et al. 1999; Othmane et al. 1999; Delague et al.
2000; Thomas, in press).
After HMSNL (Kalaydjieva et al. 1996) and CCFDN
(Angelicheva et al. 1999), this is the third novel AR hy-
pomyelinating/demyelinating neuropathy that has been
identified and genetically mapped in Romany groups de-
scended from the Vlax Romany. The clustering of pe-
ripheral myelin disorders is reminiscent of the observa-
tions in other founder populations (e.g., the occurrence
of lysosomal storage disorders among the Ashkenazi
Jews) that have given rise to the debate about the role
of genetic drift versus selection (Goodman 1979; Mo-
tulsky 1995). The clustering of peripheral neuropathies
among the Romany has important practical implications.
The independent segregation, within the same families,
of phenotypically similar but genetically distinct disor-
ders emphasizes the need for both careful evaluation of
the phenotype of every affected individual and compre-
hensive genetic analysis of the entire kindred. Although
this is not easily achieved, it should be regarded as an
essential requirement for predictive genetic testing. Be-
cause a number of affected individuals who are homo-
zygous for a given mutation may also be carriers of an-
other mutation, identification of the genes involved will
allow for the study of possible interactions and theirmod-
ifying effects.
The affected individuals in this study presented
with identical phenotypes and belong to a single kin-
dred from a closely knit Romany group with a high
frequency of consanguineous marriage. The design of
the study, which involved conventional linkage anal-
ysis rather than homozygosity mapping, was based
on the experience of previous genetic studies of the
Romany, including studies of HMSNL (Kalaydjieva
et al. 1996), limb-girdle muscular dystrophy type 2C
(LGMD2C [MIM 253700]) (Picollo et al. 1996), con-
genital glaucoma (MIM 231300) (Plasilova et al.
1998), CCFDN (Angelicheva et al. 1999), and con-
genital myasthenia (MIM 254210) (Abicht et al.
1999). Although genetic homogeneity and a single
founder mutation were invariable findings in these
studies, the conserved regions of homozygosity were
small even within individual consanguineous families.
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This pattern is likely to result from the history of the
Romany; the Romany groups of today are the prod-
uct of recent fissions of larger founder populations.
Old age of a disease-causing mutation and high fre-
quency of the mutation in the ancestral population
would lead to a diversity of disease haplotypes intro-
duced at the time of the splits into each of the cur-
rently existing endogamous, socially divergent
groups. The conserved region of homozygosity on
10q23, with an identical seven-marker haplotype
shared by all HMSNR chromosomes, unambiguously
points to a single founder mutation. At the same time,
the fact that 15 affected individuals from the Russe
kindred presented with 10 different haplotypes in the
5-cM linkage region indicates that substantial hap-
lotype diversity existed in the ancestral population of
the Vlax Romany. The current findings suggest that
HMSNR is probably a common form of AR periph-
eral neuropathy that is likely to occur in Romany
families across Europe.
The novel HMSNR gene was mapped to 10q22-23,
in close proximity to the EGR2/Krox20 gene (Joseph
et al. 1988), which is an excellent positional and func-
tional candidate gene encoding a transcription factor
with an important role in myelination and Schwann-
cell differentiation (Topilko et al. 1994). It has been
shown to be mutated in different forms of hypomyeli-
nating/demyelinating peripheral neuropathies (MIM
129010) (Warner et al. 1998; Timmerman et al. 1999).
Sequencing data as well as the identification of an in-
tragenic SNP presenting with different alleles in the af-
fected individuals allowed us to exclude EGR2. This
exclusion is further supported by the physical map of
the region, which places EGR2 ∼300 kb centromeric of
the proximal boundary of theHMSNR region. Sequenc-
ing of this part of the genome is in progress and will
result in both the identification of other candidate genes
and the positional cloning of HMSNR.
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